NAT2 polymorphisms associated with the development of hepatotoxicity after first-line tuberculosis treatment in Mexican patients: From genotype to molecular structure characterization
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 519, 153-162
Abstract
No abstract availableKeywords
Funding Information
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación
- Instituto Mexicano del Seguro Social
This publication has 32 references indexed in Scilit:
- NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapyEuropean Journal of Clinical Pharmacology, 2012
- Effects of Single Nucleotide Polymorphisms on Human N-Acetyltransferase 2 Structure and Dynamics by Molecular Dynamics SimulationPLOS ONE, 2011
- MPT 64 Antigen detection for Rapid confirmation of M.tuberculosis isolatesBMC Research Notes, 2011
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Worldwide distribution of NAT2 diversity: Implications for NAT2 evolutionary historyBMC Genomic Data, 2008
- Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2Carcinogenesis, 2007
- Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populationsPharmacogenetics, 1996
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996
- Criteria of drug-induced liver disordersJournal of Hepatology, 1990
- Comparison of simple potential functions for simulating liquid waterThe Journal of Chemical Physics, 1983